Effectiveness and cost-effectiveness of a novel, group self-management course for adults with chronic musculoskeletal pain: study protocol for a multicentre, randomised controlled trial (COPERS)

Carnes, Dawn, Taylor, Stephanie J C, Homer, Kate, Eldridge, Sandra, Bremner, Stephen, Pincus, Tamar, Rahman, Anisur and Underwood, Martin (2013) Effectiveness and cost-effectiveness of a novel, group self-management course for adults with chronic musculoskeletal pain: study protocol for a multicentre, randomised controlled trial (COPERS). BMJ Open, 3 (1). e002492. ISSN 20446055

[img]
Preview
PDF - Published Version
Available under License Creative Commons Attribution-NonCommercial.

Download (397kB) | Preview

Abstract

Introduction: Chronic musculoskeletal pain is a common condition that often responds poorly to treatment. Self-management courses have been advocated as a non-drug pain management technique, although evidence for their effectiveness is equivocal. We designed and piloted a self-management course based on evidence for effectiveness for specific course components and characteristics. Methods/analysis: COPERS (coping with persistent pain, effectiveness research into self-management) is a pragmatic randomised controlled trial testing the effectiveness and cost-effectiveness of an intensive, group, cognitive behavioural-based, theoretically informed and manualised self-management course for chronic pain patients against a control of best usual care: a pain education booklet and a relaxation CD. The course lasts for 15 h, spread over 3 days, with a –2 h follow-up session 2 weeks later. We aim to recruit 685 participants with chronic musculoskeletal pain from primary, intermediate and secondary care services in two UK regions. The study is powered to show a standardised mean difference of 0.3 in the primary outcome, pain-related disability. Secondary outcomes include generic health-related quality of life, healthcare utilisation, pain self-efficacy, coping, depression, anxiety and social engagement. Outcomes are measured at 6 and 12 months postrandomisation. Pain self-efficacy is measured at 3 months to assess whether change mediates clinical effect. Ethics/dissemination: Ethics approval was given by Cambridgeshire Ethics 11/EE/046. This trial will provide robust data on the effectiveness and cost-effectiveness of an evidence-based, group self-management programme for chronic musculoskeletal pain. The published outcomes will help to inform future policy and practice around such self-management courses, both nationally and internationally. Trial registration: ISRCTN24426731.

Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Brighton and Sussex Medical School
Brighton and Sussex Medical School > Primary Care and Public Health
Depositing User: Jane Hale
Date Deposited: 16 Jun 2015 15:36
Last Modified: 22 Mar 2017 11:48
URI: http://sro.sussex.ac.uk/id/eprint/54580

View download statistics for this item

📧 Request an update
Project NameSussex Project NumberFunderFunder Ref
Programme Grants for Applied Research schemeUnsetNational Institute for Health Research (NIHR)RP-PG-0707-10189
UnsetUnsetBirmingham Science City Translational Medicine Clinical Research and Infrastructure Trials Platform, with support from Advantage West MidlandsUnset